Physician profile
Apar Gupta
NPI 1407237845
$5,579.51
in general payments reported to CMS, 2019-2025
34 companies · $997 in 2025
The $997 reported for 2025 was more than what 83% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.05 · 2023: $2,019 · 2024: $2,548 · 2025: $997.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,564 · Travel and Lodging: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,564.46 |
| Travel and Lodging | $2,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gt Medical Technologies, INC | $2,815.26 | 2023-2024 | Gammatile, Gammatile |
| Novartis Pharmaceuticals Corporation | $221.82 | 2023-2025 | |
| Novocure INC. | $215.80 | 2020-2025 | Optune, Optune Gio |
| Astrazeneca Pharmaceuticals Lp | $208.81 | 2024-2025 | Imfinzi |
| Abbvie INC. | $197.16 | 2024-2025 | |
| Steris Corporation | $185.97 | 2023 | |
| Sobi, INC | $182.29 | 2024-2025 | |
| Telix Pharmaceuticals | $161.58 | 2024-2025 | Illuccix |
| Genmab U.S., INC. | $155.04 | 2024-2025 | Tivdak, Epkinly |
| Daiichi Sankyo INC. | $115.93 | 2024 | Enhertu |
| Monteris Medical Corporation | $113.50 | 2023 | Neuroblate |
| Seagen INC. | $105.93 | 2023 | Tukysa |
| Merck Sharp & Dohme LLC | $105.44 | 2024 | Keytruda, Lynparza |
| Icotec Medical INC. | $104.33 | 2023 | Icotec Blackarmor Spine System |
| Bayer Healthcare Pharmaceuticals INC. | $70.24 | 2024-2025 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $67.82 | 2024-2025 | |
| Progenics Pharmaceuticals, INC. | $53.30 | 2023-2024 | Pylarify |
| Stemline Therapeutics INC. | $50.43 | 2023-2024 | Orserdu |
| Davol INC. | $50.38 | 2025 | Progel Applicator Spray Tips |
| Emd Serono, INC. | $42.26 | 2025 | |
| Tersera Therapeutics LLC | $36.85 | 2024 | Zoladex |
| Puma Biotechnology, INC. | $29.90 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $29.83 | 2024 | Onivyde |
| Adaptive Biotechnologies Corporation | $27.82 | 2025 | Clonoseq |
| Eisai INC. | $27.20 | 2024 | |
| Syndax Pharmaceuticals, INC. | $26.69 | 2025 | |
| Lilly USA, LLC | $25.85 | 2024 | Verzenio |
| Rigel Pharmaceuticals, INC. | $25.65 | 2024 | Tavalisse, Rezlidhia |
| Janssen Biotech, INC. | $25.51 | 2025 | Talvey, Tecvayli |
| Biocon Biologics INC | $22.94 | 2025 | Yesintek |
| Agios Pharmaceuticals, INC. | $20.87 | 2024 | Pyrukynd |
| Springworks Therapeutics, INC. | $20.32 | 2025 | Ogsiveo |
| Legend Biotech USA INC. | $19.79 | 2024 | |
| Boston Scientific Corporation | $17.00 | 2025 | Spaceoar Vue System - 10ml |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Apar Gupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.